Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826) has released an update.
Shanghai Haohai Biological Technology Co., Ltd. has established an audit committee to enhance its corporate governance by ensuring effective supervision of financial affairs and business activities. The committee, mainly composed of independent non-executive directors with accounting expertise, is tasked with overseeing the relationship with the company’s auditor and ensuring their independence. This move is part of the company’s efforts to strengthen decision-making and maintain transparency in its operations.
For further insights into HK:6826 stock, check out TipRanks’ Stock Analysis page.